COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Earnings & Estimates
USA - NASDAQ:COLL - US19459J1043 - Common Stock
43.95 USD
-0.52 (-1.17%)
43.95 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 463.9M 67.53% | 566.767M 22.17% | 631.449M 11.41% | 766.66M 21.41% | 791.77M 3.28% | 734.46M -7.24% | 675M -8.10% | 748.02M 10.82% | 779.99M 4.27% | 853.54M 9.43% | 573.75M -32.78% | |
| EBITDA YoY % growth | 203.6M 116.60% | 324.717M 59.49% | 339.055M 4.42% | 449.64M 32.62% | 441.12M -1.89% | 373.83M -15.25% | 378.06M 1.13% | 391.43M 3.54% | 425.34M 8.66% | N/A | N/A | |
| EBIT YoY % growth | 69.4M 176.49% | 175.461M 152.83% | 169.895M -3.17% | 351.57M 106.93% | 372.05M 5.83% | 365.08M -1.87% | 365.77M 0.19% | 375.46M 2.65% | 390.66M 4.05% | N/A | N/A | |
| Operating Margin | 14.96% | 30.96% | 26.91% | 45.86% | 46.99% | 49.71% | 54.19% | 50.19% | 50.09% | N/A | N/A | |
| EPS YoY % growth | 0.56 43.59% | 1.18 110.71% | 6.45 446.61% | 9.07 40.67% | 8.51 -6.24% | 7.60 -10.68% | 4.70 -38.18% | 5.81 23.78% | 6.13 5.44% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.32 30.93% | 1.77 18.77% | 1.80 7.16% | 1.82 -19.08% | 1.87 -19.23% |
| Revenue Q2Q % growth | 208.67M 14.69% | 197.84M 11.30% | 194.95M 3.70% | 198.65M -5.12% | 203.08M -2.68% |
| EBITDA Q2Q % growth | 120.34M -41.94% | 115.51M 47.61% | 119.04M -19.72% | 123.28M -46.81% | 128.83M 7.06% |
| EBIT Q2Q % growth | 113.64M 198.18% | 72.154M 232.71% | 71.799M 104.53% | 73.075M 17.70% | 76.428M -32.75% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.25 39.75% | 2.08 | 0.17 | 7.92% |
| Q2 2025 Q2Q % growth | 1.68 3.70% | 1.65 | 0.03 | 1.88% |
| Q1 2025 Q2Q % growth | 1.49 2.76% | 1.46 | 0.03 | 1.96% |
| Q4 2024 Q2Q % growth | 1.77 115.85% | 1.57 | 0.20 | 12.85% |
| Q3 2024 Q2Q % growth | 1.61 203.77% | 1.62 | -0.01 | -0.88% |
| Q2 2024 Q2Q % growth | 1.62 376.47% | 1.51 | 0.11 | 6.95% |
| Q1 2024 Q2Q % growth | 1.45 384.31% | 0.96 | 0.49 | 51.47% |
| Q4 2023 Q2Q % growth | 0.82 490.48% | 0.67 | 0.15 | 21.81% |
| Q3 2023 Q2Q % growth | 0.53 5,200.00% | 0.53 | 0.00 | 0.57% |
| Q2 2023 Q2Q % growth | 0.34 6.25% | 0.29 | 0.05 | 15.94% |
| Q1 2023 Q2Q % growth | -0.51 -215.91% | 0.32 | -0.83 | -259.24% |
| Q4 2022 Q2Q % growth | -0.21 58.82% | -0.15 | -0.06 | -41.99% |
| Q3 2022 Q2Q % growth | 0.01 -95.45% | -0.14 | 0.15 | 107.26% |
| Q2 2022 Q2Q % growth | 0.32 18.52% | 1.45 | -1.13 | -77.95% |
| Q1 2022 Q2Q % growth | 0.44 7.32% | 0.91 | -0.47 | -51.83% |
| Q4 2021 Q2Q % growth | -0.51 -355.00% | 1.06 | -1.57 | -148.21% |
| Q3 2021 Q2Q % growth | 0.22 -31.25% | 0.97 | -0.75 | -77.34% |
| Q2 2021 Q2Q % growth | 0.27 17.39% | 0.48 | -0.21 | -43.92% |
| Q1 2021 Q2Q % growth | 0.41 4,000.00% | 0.43 | -0.02 | -4.75% |
| Q4 2020 Q2Q % growth | 0.20 385.71% | 0.40 | -0.20 | -49.51% |
| Q3 2020 Q2Q % growth | 0.32 277.78% | 0.42 | -0.10 | -23.21% |
| Q2 2020 Q2Q % growth | 0.23 264.29% | 0.31 | -0.08 | -26.07% |
| Q1 2020 Q2Q % growth | 0.01 103.45% | 0.42 | -0.41 | -97.62% |
| Q4 2019 Q2Q % growth | -0.07 | -0.09 | 0.02 | 19.93% |
| Q3 2019 Q2Q % growth | -0.18 | -0.12 | -0.06 | -48.83% |
| Q2 2019 Q2Q % growth | -0.14 | -0.18 | 0.04 | 20.60% |
| Q1 2019 Q2Q % growth | -0.29 | -0.24 | -0.05 | -22.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 209.361M 31.42% | 192.9M | 16.461M | 8.53% |
| Q2 2025 Q2Q % growth | 188M 29.41% | 184.5M | 3.5M | 1.90% |
| Q1 2025 Q2Q % growth | 177.757M 22.66% | 175.4M | 2.357M | 1.34% |
| Q4 2024 Q2Q % growth | 181.949M 21.51% | 183.39M | -1.441M | -0.79% |
| Q3 2024 Q2Q % growth | 159.301M 16.52% | 158.69M | 611K | 0.39% |
| Q2 2024 Q2Q % growth | 145.276M 7.18% | 146.82M | -1.544M | -1.05% |
| Q1 2024 Q2Q % growth | 144.923M 0.11% | 149.79M | -4.867M | -3.25% |
| Q4 2023 Q2Q % growth | 149.745M 15.54% | 150.78M | -1.035M | -0.69% |
| Q3 2023 Q2Q % growth | 136.71M 7.65% | 141.03M | -4.32M | -3.06% |
| Q2 2023 Q2Q % growth | 135.546M 9.75% | 141.17M | -5.624M | -3.98% |
| Q1 2023 Q2Q % growth | 144.767M 72.75% | 141.24M | 3.527M | 2.50% |
| Q4 2022 Q2Q % growth | 129.6M 372.99% | 127.7M | 1.9M | 1.49% |
| Q3 2022 Q2Q % growth | 127M 61.17% | 126.82M | 180K | 0.14% |
| Q2 2022 Q2Q % growth | 123.5M 48.97% | 124.09M | -590K | -0.48% |
| Q1 2022 Q2Q % growth | 83.8M -4.45% | 80.461M | 3.339M | 4.15% |
| Q4 2021 Q2Q % growth | 27.4M -64.09% | 83.24M | -55.84M | -67.08% |
| Q3 2021 Q2Q % growth | 78.8M -0.51% | 86.589M | -7.789M | -9.00% |
| Q2 2021 Q2Q % growth | 82.9M 6.15% | 86.468M | -3.568M | -4.13% |
| Q1 2021 Q2Q % growth | 87.7M 14.64% | 83.503M | 4.197M | 5.03% |
| Q4 2020 Q2Q % growth | 76.3M 2.83% | 78.955M | -2.655M | -3.36% |
| Q3 2020 Q2Q % growth | 79.2M 8.64% | 78.977M | 223K | 0.28% |
| Q2 2020 Q2Q % growth | 78.1M 4.13% | 75.893M | 2.207M | 2.91% |
| Q1 2020 Q2Q % growth | 76.5M 2.68% | 78.21M | -1.71M | -2.19% |
| Q4 2019 Q2Q % growth | 74.2M | 74.799M | -599K | -0.80% |
| Q3 2019 Q2Q % growth | 72.9M | 75.809M | -2.909M | -3.84% |
| Q2 2019 Q2Q % growth | 75M | 77.34M | -2.34M | -3.03% |
| Q1 2019 Q2Q % growth | 74.5M | 72.233M | 2.267M | 3.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.52% | 14.25% | 7.69% | 29.1% |
| Revenue | 2.44% | 5.37% | -0.67% | 0.78% |